This award was created in September 1998 to honor Professor Alex Leighton, a pioneer and leader of Canadian psychiatric epidemiology at his 90th anniversary in Halifax. His work has associated innovative scientific endeavours with humanistic values and social concerns. Professor Leighton is known as a great communicator and teacher; he has trained and inspired generations of psychiatric epidemiologists and scientists.
The Alex Leighton Award is a joint initiative of the CPA and the Canadian Academy of Psychiatric Epidemiology (CAPE). Its purpose is to recognize an individual or a group of individuals who have contributed significantly to advancing and diffusing Canadian psychiatric epidemiology through innovative studies, methods, teaching or transfer of knowledge. It can relate to lifelong activities or to a recent significant achievement by more junior scientists.
The nominee’s work must be easily recognized as
- a significant contribution to Canadian psychiatric epidemiology;
- studies or activities conducted in Canada; and/or
- a contribution to psychiatric epidemiology on the international scene.
Nominations must include:
- a 250-word statement by the nominator on the nominee’s eligibility; and
- a one-page summary supporting the candidature and a complete curriculum vitae, submitted jointly by the nominee and nominators.
Nominations must be received by February 1 of each year.
Send nominations to:
President, Canadian Academy of Psychiatric Epidemiology (CAPE)
c/o CPA Head Office
141 Laurier Ave. West, Suite 701
Ottawa, ON K1P 5J3
The Executive of the Canadian Academy of Psychiatric Epidemiology forms a three-person award committee each year. It includes the president and secretary of CAPE. This award committee decides by consensus.
This award recognizes the individual or group responsible for excellence in the planning, content development, delivery and evaluation of a CE activity in psychiatry in Canada.
The Glenda M. MacQueen Memorial Career Development Award for Women in Psychiatry has been created to honour the remarkable accomplishments of the late Glenda MacQueen, through the creation of a career development award (CDA) to support the early-stage development of women who will lead the future of academic psychiatry. As a legacy to Glenda’s contributions to research, training, clinical service, administrative service and mentorship, The Institute of Neurosciences, Mental Health and Addiction (INMHA), in collaboration with the Canadian Psychiatric Association (CPA), seeks to provide financial resources to enhance the potential success of future women leaders who can rise to some of these critical elements of academic achievement in mental health.